Thomas Schott, MD
Orthopedic Surgery · Irving, TXNPI 1982699518
Payments from drug & device makers
What this record shows
Pacira Pharmaceuticals Incorporated accounts for 65.7% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $694 and has fallen 97.6% since, to $17 in 2025. That places this record below the midpoint for orthopedic surgery clinicians in TX, where the typical reported total is $1,877.
Across 9 payments — averaging $114.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$676
- Smith+Nephew$227
- Vericel Corporation$109
- Pylant Medical$17
What the payments were for
- Travel & lodging$50849%
- Food & beverage$52051%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 5 | $676 |
| Smith+Nephew | 2 | $227 |
| Vericel Corporation | 1 | $109 |
| Pylant Medical | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$508
- INTEllIO LINK WEREWOLF$134
- LENS 4K$134
- EXPAREL$115
- MACI$109
How this compares
$1,028 in reported general payments places this provider in the 30th percentile of 33 orthopedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 105 | $960 |
| Meloxicam | 181 | $453 |
| Methylprednisolone | 32 | $267 |
| Penicillin V Potassium | 85 | $189 |
| Tramadol Hcl | 16 | $41 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Irving
- Mark GreenbergIrving$9K
- Bing TsayIrving$1K
- Steven BrotzmanAustin$336K
- Rajesh ArakalPlano$79K
- Mark ScioliLubbock$70K
- John SimsAmarillo$35K
- Katherine LiHouston$19K
- Jason RamseyLubbock$13K
- Michael MarkowitzPlano$13K
- Bradley HarmanCleburne$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.